Satyanarayana Medicherla

Author

University of Michigan

Also Known As

S MEDICHERLA, S Medicherla, S. Medicherla, Satyanarayana Medicherla

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

University of Michigan Imperial College London Geriatric Research Education and Clinical Center Beckman Research Institute Stanford University

About

Satyanarayana Medicherla is an author at University of Michigan specializing in medicine, pharmacology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	520
2	Cell Biology	7	7	289
3	Health Sciences	2	2	89
4	Allergy	2	2	64
5	Biochemistry	2	2	75

Satyanarayana Medicherla

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide Dawn R. Cochrane, Sebastián Bernales, Britta M. Jacobsen, Breast Cancer Research	2014	391
Inhibition of the TGF-β receptor I kinase promotes hematopoiesis in MDS Li Zhou, Aaron Nguyen, Davendra Sohal, Blood	2008	177
Inhibition of Transforming Growth Factor β Signaling Reduces Pancreatic Adenocarcinoma Growth and Invasiveness N. J. Gaspar, Lingyun Li, Ann M. Kapoun, Molecular Pharmacology	2007	118
p38α-Selective Mitogen-Activated Protein Kinase Inhibitor SD-282 Reduces Inflammation in a Subchronic Model of Tobacco Smoke-Induced Airway Inflammation Satyanarayana Medicherla, Mary F. Fitzgerald, Dianne Spicer, Journal of Pharmacology and Experimental Therapeutics	2007	94
Inhibition of p38α MAPK enhances proteasome inhibitor-induced apoptosis of myeloma cells by modulating Hsp27, Bcl-XL, Mcl-1 and p53 levels in vitro and inhibits tumor growth in vivo Tony Navas, Anthony Nguyen, Teru Hideshima, Leukemia Tumor BiologyP53 LevelsMedicineApoptosisMyeloma Cells	2006	80
A Selective p38α Mitogen-Activated Protein Kinase Inhibitor Reverses Cartilage and Bone Destruction in Mice with Collagen-Induced Arthritis Satyanarayana Medicherla, Ying Jing, Ruban Mangadu, Journal of Pharmacology and Experimental Therapeutics	2006	77
Transforming Growth Factor-β Blockade Down-Regulates the Renin-Angiotensin System and Modifies Cardiac Remodeling after Myocardial Infarction Leigh J. Ellmers, Nicola Scott, Satyanarayana Medicherla, Endocrinology	2008	67
A p38α Selective Mitogen-Activated Protein Kinase Inhibitor Prevents Periodontal Bone Loss Keith L. Kirkwood, Fei Li, Jill E. Rogers, Journal of Pharmacology and Experimental Therapeutics	2006	67
Antinociceptive action of a p38α MAPK inhibitor, SD-282, in a diabetic neuropathy model Sarah M. Sweitzer, Satyanarayana Medicherla, Ramona G. Almirez, Pain Pain DisordersPain MedicineNeuropathic PainP38α Mapk InhibitorMolecular Pharmacology	2004	66
Normalizing the bone marrow microenvironment with p38 inhibitor reduces multiple myeloma cell proliferation and adhesion and suppresses osteoclast formation Aaron Nguyen, Elizabeth G. Stebbins, Margaret Henson, Experimental Cell Research Hematological MalignancyBone Morphogenic ProteinMalignant Blood DisorderHematologyImmunology	2006	64

Page 1